Current concepts in long COVID-19 brain fog and... (2024 study) Skip to main content
Prospective Study Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024

Current concepts in long COVID-19 brain fog and postural orthostatic tachycardia syndrome.

Tavee J, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The author wrote a review of what is known about long COVID brain fog and postural orthostatic tachycardia syndrome (POTS), including their possible causes and treatments.

What They Found

This narrative review of long COVID nervous system complications reports that brain fog and POTS strongly affect quality of life and ability to return to work, and that the cause is unknown but likely has many parts. The abstract names immune dysregulation and small blood vessel problems as playing central roles. It reports that brain fog affects 10% to 88% of people after COVID-19, depending on the virus variant and whether the person was hospitalized, while the rate of long COVID POTS is unknown. Treatment is mostly supportive. The abstract says marginal benefits were found with cognitive behavioural therapy, hyperbaric oxygen therapy, and supplements for brain fog. Prospective studies showed that some patients still had symptoms and nerve-related deficits a year after infection.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a review of other work, not a new trial, and it gives no HBOT protocol or study details, so the marginal benefit it mentions cannot be judged from the abstract alone.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Prospective Study
Category Neurological
Source Pubmed
PubMed ID 39154907
Year Published 2024
Journal Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
MeSH Terms Humans; Postural Orthostatic Tachycardia Syndrome; COVID-19; Post-Acute COVID-19 Syndrome; SARS-CoV-2; Cognitive Dysfunction; Quality of Life; Cognitive Behavioral Therapy

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology